Hyperglycaemia in pregnancy (HIP) is categorized as pregestational diabetes, gestational diabetes mellitus (GDM), or diabetes in pregnancy (DIP) based on timing and severity of diagnosis. GDM accounts for 75–90% of HIP cases. Pre-existing type 2 diabetes and type 1 diabetes in pregnancy are rising, with newer technologies aiding in management. According to DIPSI guidelines, testing for GDM should be done in the first trimester or before 12 weeks repeated at 24-28 weeks if negative( with at least a 4 weeks gap) and again at 32-34 weeks if the second test is also negative.
GDM is linked to increased future risk of type 2 diabetes and cardiovascular disease in mothers, and higher chances of obesity and diabetes in their children, highlighting the importance of early interventions. We invite you to join an exclusive webinar featuring three distinguished experts Dr. Fessy Louis T, Dr. Bipin…
